This petition was submitted during the 2015–2017 Conservative government
Petition Reinstate bevacizumab (Avastin) for cervical cancer on the Cancer Drugs Fund
Jo’s Cervical Cancer Trust is calling for the drug bevacizumab (Avastin) for cervical cancer to be reinstated onto the Cancer Drugs Fund (CDF) list after the announcement that it will be de-listed for cervical cancer treatment from the 4th November 2015.
More details
Without bevacizumab, hundreds of women annually with late stage cervical cancer will be denied a drug that has shown to increase the median survival by 3.7 months with a small impact on quality of life.
The removal of bevacizumab, which had just started to fulfill a large and unmet need, will result in a hugely detrimental impact on end of life for cervical cancer patients.
We’re calling on NHS England and Pharma to resolve this issue and come to an agreement on affordability.
This petition is closed This petition ran for 6 months
Related activity
House of Commons debate on the availability of cancer drugs
On Tuesday 20 October there was a House of Commons debate in Westminster Hall on the availability of cancer drugs. A Government Minister took part in the debate and responded to the points raised.
You can find more information and watch/ listen to the debate or read the transcript by visiting:
http://www.parliament.uk/business/news/2015/october/westminster-hall-debates-20-october-2015/
You can follow the House of Commons on Twitter: @HouseofCommons